Predictive Modeling of Drug Response in Non-Hodgkin’s Lymphoma
Open Access
- 10 June 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (6) , e0129433
Abstract
We combine mathematical modeling with experiments in living mice to quantify the relative roles of intrinsic cellular vs. tissue-scale physiological contributors to chemotherapy drug resistance, which are difficult to understand solely through experimentation. Experiments in cell culture and in mice with drug-sensitive (Eµ-myc/Arf-/-) and drug-resistant (Eµ-myc/p53-/-) lymphoma cell lines were conducted to calibrate and validate a mechanistic mathematical model. Inputs to inform the model include tumor drug transport characteristics, such as blood volume fraction, average geometric mean blood vessel radius, drug diffusion penetration distance, and drug response in cell culture. Model results show that the drug response in mice, represented by the fraction of dead tumor volume, can be reliably predicted from these inputs. Hence, a proof-of-principle for predictive quantification of lymphoma drug therapy was established based on both cellular and tissue-scale physiological contributions. We further demonstrate that, if the in vitro cytotoxic response of a specific cancer cell line under chemotherapy is known, the model is then able to predict the treatment efficacy in vivo. Lastly, tissue blood volume fraction was determined to be the most sensitive model parameter and a primary contributor to drug resistance.Keywords
This publication has 50 references indexed in Scilit:
- Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurementsProceedings of the National Academy of Sciences, 2013
- Impact of Diffusion Barriers to Small Cytotoxic Molecules on the Efficacy of Immunotherapy in Breast CancerPLOS ONE, 2013
- Predictions of tumour morphological stability and evaluation against experimental observationsJournal of The Royal Society Interface, 2010
- Three-dimensional multispecies nonlinear tumor growth—II: Tumor invasion and angiogenesisJournal of Theoretical Biology, 2010
- Cross-scale, cross-pathway evaluation using an agent-based non-small cell lung cancer modelBioinformatics, 2009
- Prediction of Drug Response in Breast Cancer Using Integrative Experimental/Computational ModelingCancer Research, 2009
- Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulationJournal of Mathematical Biology, 2008
- Cross-scale sensitivity analysis of a non-small cell lung cancer model: Linking molecular signaling properties to cellular behaviorBioSystems, 2008
- Biology and treatment of Burkittʼs lymphomaCurrent Opinion in Hematology, 2007
- A spatiotemporal, patient individualized simulation model of solid tumor response to chemotherapy in vivo: the paradigm of glioblastoma multiforme treated by temozolomideIEEE Transactions on Biomedical Engineering, 2006